Meeder Asset Management Inc United Therapeutics Corp Transaction History

Meeder Asset Management Inc

  • $1.48 Billion
  • Q3 2024

A detailed history of Meeder Asset Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Meeder Asset Management Inc holds 18 shares of UTHR stock, worth $6,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 18 -0.0%
Holding current value
$6,712
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$228.26 - $319.04 $4,108 - $5,742
18 New
18 $5,000
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $8,945 - $10,743
-44 Reduced 13.79%
275 $58,000
Q2 2022

Aug 08, 2022
SELL
$174.81 - $241.14 $10,313 - $14,227
-59 Reduced 15.61%
319 $75,000
Q1 2022

May 10, 2022
BUY
$166.16 - $213.96 $62,808 - $80,876
378 New
378 $68,000
Q4 2021

Feb 11, 2022
SELL
$184.32 - $216.08 $1.24 Million - $1.45 Million
-6,730 Closed
0 $0
Q3 2021

Nov 08, 2021
SELL
$179.86 - $214.88 $34,533 - $41,256
-192 Reduced 2.77%
6,730 $1.24 Million
Q2 2021

Aug 09, 2021
SELL
$170.47 - $211.93 $394,638 - $490,617
-2,315 Reduced 25.06%
6,922 $1.24 Million
Q1 2021

Apr 28, 2021
BUY
$153.94 - $174.85 $1.38 Million - $1.56 Million
8,949 Added 3107.29%
9,237 $1.54 Million
Q4 2020

Feb 09, 2021
SELL
$101.87 - $151.79 $720,933 - $1.07 Million
-7,077 Reduced 96.09%
288 $44,000
Q3 2020

Nov 02, 2020
BUY
$99.9 - $121.13 $32,667 - $39,609
327 Added 4.65%
7,365 $744,000
Q2 2020

Aug 11, 2020
SELL
$92.74 - $125.82 $6,491 - $8,807
-70 Reduced 0.98%
7,038 $852,000
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $7,780 - $11,304
-98 Reduced 1.36%
7,108 $675,000
Q4 2019

Feb 13, 2020
BUY
$78.31 - $95.34 $186,691 - $227,290
2,384 Added 49.44%
7,206 $635,000
Q3 2019

Oct 17, 2019
SELL
$74.85 - $85.99 $44,460 - $51,078
-594 Reduced 10.97%
4,822 $385,000
Q2 2019

Aug 05, 2019
SELL
$76.06 - $120.81 $84,426 - $134,099
-1,110 Reduced 17.01%
5,416 $423,000
Q1 2019

Apr 16, 2019
SELL
$107.15 - $126.84 $241,301 - $285,643
-2,252 Reduced 25.66%
6,526 $766,000
Q4 2018

Jan 17, 2019
SELL
$101.4 - $128.73 $44,514 - $56,512
-439 Reduced 4.76%
8,778 $956,000
Q3 2018

Nov 02, 2018
SELL
$113.81 - $129.46 $297,726 - $338,667
-2,616 Reduced 22.11%
9,217 $0
Q2 2018

Jul 24, 2018
BUY
$101.14 - $118.31 $348,123 - $407,223
3,442 Added 41.02%
11,833 $0
Q1 2018

May 03, 2018
SELL
$107.21 - $151.94 $42,776 - $60,624
-399 Reduced 4.54%
8,391 $943,000
Q4 2017

Feb 02, 2018
BUY
$118.58 - $151.28 $156,051 - $199,084
1,316 Added 17.61%
8,790 $1.3 Million
Q3 2017

Oct 20, 2017
BUY
$114.6 - $136.81 $856,520 - $1.02 Million
7,474
7,474 $876,000

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email